Executive Summary: State-of-The-Art Review: Contemporary Management of Staphylococcus aureus Bacteremia: Controversies in Clinical Practice

Clin Infect Dis. 2023 Nov 30;77(11):1489-1491. doi: 10.1093/cid/ciad525.

Authors

Daniel J Minter¹, Ayesha Appa^{1

2}, Henry F Chambers^{1

2}, Sarah B Doernberg¹

Affiliations

¹ Division of Infectious Diseases, Department of Medicine, University of California, San Francisco, San Francisco, California, USA.
² Division of HIV, Infectious Diseases, and Global Medicine at Zuckerberg San Francisco General Hospital, Department of Medicine, University of California, San Francisco, San Francisco, California, USA.

PMID: 38031168
DOI: 10.1093/cid/ciad525

No abstract available

Publication types

Review

MeSH terms

Anti-Bacterial Agents / therapeutic use
Bacteremia* / diagnosis
Bacteremia* / drug therapy
Humans
Methicillin-Resistant Staphylococcus aureus*
Staphylococcal Infections* / diagnosis
Staphylococcal Infections* / drug therapy
Staphylococcus aureus

Substances

Anti-Bacterial Agents